Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040416 · ClinicalTrials.gov registry record
Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass
A clinical trial of Bleeding Marginal Ulcer, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT01040416 is a study of Bleeding Marginal Ulcer that has completed, run by University of California, San Francisco. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01040416, a study of Bleeding Marginal Ulcer, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYGB) surgery.
Conditions Studied
Study Locations (1)
California
- UCSF Fresno Center for Medical Education and Research - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01040416
The ClinicalTrials.gov registry entry for NCT01040416 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bleeding Marginal Ulcer appearing as the primary indexed condition, and to 0 interventions.
NCT01040416 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01040416 about?
NCT01040416 is a clinical study titled "Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass". The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYG...
What is the current status of trial NCT01040416?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-12. Estimated completion is 2009-12.
What conditions does trial NCT01040416 study?
This clinical trial studies the following conditions: Bleeding Marginal Ulcer.
Who is sponsoring clinical trial NCT01040416?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040416 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.